InspireMD, Inc. Financial Ratios
NSPR|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.42 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-88.7%
Profit Margin
-456.6%
Net Income / Revenue
Asset Turnover
0.10
Revenue / Total Assets
Equity Multiplier
1.92
Total Assets / Equity
Composite: -88.7% (reported: -88.7%)
Profitability
Liquidity
Current Ratio
5.74
Quick Ratio
5.42
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.10
Inventory Turnover
1.62
Days Sales Outstanding
113 days
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026
Earnings Quality
Accrual Ratio
-17.4%
-9.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.